Patent Infringement: Delhi High Court Restrains Zydus From Manufacturing Biologic Similar To 'Nivolumab' Cancer Drug
Nupur Thapliyal
19 July 2025 10:00 PM IST

Next Story
19 July 2025 10:00 PM IST
The Delhi High Court has restrained Zydus Lifesciences Limited from manufacturing, selling importing, exporting or dealing in any biologic which is similar to Nivolumab, a drug used to treat cancer, sold under the brand name “Opdivo.”Justice Mini Pushkarna passed the interim order in favour of Nivolumab's manufacturer company- E.R. Squibb and Sons LLC, in its patent infringement suit...
Your support helps us to bring you more content at
an affordable subscription scheme !!!
All payment options available
